Schonfeld Strategic Advisors’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-358,400
| Closed | -$1.65M | – | 1735 |
|
|
2023
Q3 | $1.65M | Buy |
358,400
+211,000
| +143% | +$971K | 0.01% | 766 |
|
|
2023
Q2 | $952K | Buy |
147,400
+65,500
| +80% | +$423K | 0.01% | 985 |
|
|
2023
Q1 | $618K | Sell |
81,900
-72,900
| -47% | -$550K | 0.01% | 1096 |
|
|
2022
Q4 | $1.57M | Sell |
154,800
-67,900
| -30% | -$688K | 0.01% | 924 |
|
|
2022
Q3 | $2.2M | Buy |
222,700
+84,400
| +61% | +$835K | 0.02% | 821 |
|
|
2022
Q2 | $1.47M | Buy |
138,300
+14,400
| +12% | +$153K | 0.01% | 785 |
|
|
2022
Q1 | $1.21M | Buy |
+123,900
| New | +$1.21M | 0.01% | 848 |
|
|
2021
Q4 | – | Sell |
-57,540
| Closed | -$1.15M | – | 1918 |
|
|
2021
Q3 | $1.15M | Buy |
+57,540
| New | +$1.15M | 0.01% | 836 |
|